The RPL37 gene gives cells instructions for making one part of the ribosome, the protein making structure found in every cell. Your cells depend on this gene when they need to build proteins for growth, repair, and normal day to day function. If the RPL37 gene does not work properly, cells may make proteins less efficiently, which can interfere with how tissues grow and function.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some hold the directions for producing proteins, the parts of cells that do much of the work. Others mainly help direct when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
RPL37Gene function
What if the gene works
The RPL37 gene helps make a protein used in ribosomes, the cell structures that build other proteins. This supports normal cell growth, renewal, and tissue maintenance.
Risk
What if the gene does not work
Changes in the RPL37 gene can reduce ribosome assembly and are linked to Diamond-Blackfan anemia, often causing low red blood cell production; milder to more severe variants may influence how early problems appear and whether growth or physical differences occur.
Treatment
What does that mean for your treatment
No treatment or drug choice guidance is currently established specifically for pathogenic variants in the RPL37 gene. Care is based on the condition a person has and standard supportive treatment, not on an RPL37-directed medicine.
Gene function
What if the gene works
Every day, your cells need to make new proteins to grow, repair themselves, and keep tissues working. The RPL37 gene helps build the ribosome, the cell's protein making machine. This is a key part of how your cells make proteins in a steady, controlled way.
The RPL37 gene provides one of the proteins that forms the larger half of the ribosome. This helps give the ribosome the right shape and stability so it can work smoothly.
Once ribosomes are assembled, this gene supports the step where cells turn genetic instructions into proteins. Those proteins are needed for everyday tasks such as growth, repair, and routine cell upkeep.
Inside the nucleolus (the area where ribosomes are built), the RPL37 gene helps new ribosomes assemble around ribosomal RNA, a core part of the ribosome. This supports efficient, orderly ribosome assembly.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RPL37 gene can change the amount or shape of the RPL37 protein, which may make ribosomes, the cell structures that build proteins, less stable. How variants influence the RPL37 gene's function often depends on severity: milder changes may partly reduce protein output, while more severe variants can stop enough protein from being made. This can interfere with ribosome assembly and reduce the cell's ability to make proteins normally.
How variants are linked to conditions
RPL37 does not yet have a broadly confirmed link to a specific health condition, so information on how variants of the RPL37 gene are linked to conditions is still evolving. Anyone with a confirmed RPL37-related finding should use their doctor’s or genetic counselor’s advice to understand what it may mean for their health.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RPL37 gene. Anyone with concerns about personal or family risk can speak with a doctor or genetic counselor.
Inheritance of RPL37 variants
Understanding how RPL37 gene variants are inherited can help make sense of who in a family may also carry the change. When RPL37 is linked to disease, it is inherited in an autosomal dominant pattern, which means a person needs one altered copy of the RPL37 gene to be affected. A parent carrying the variant has a 50% chance of passing it on in each pregnancy, regardless of the child’s sex. Some people have a new, de novo variant in the RPL37 gene, meaning it started in them and was not inherited from either parent.
What does my RPL37 result mean for my family?
A harmful change in the RPL37 gene is linked to an inherited form of Diamond-Blackfan anemia, and close relatives can sometimes have the same gene change, even if their symptoms are milder or different. Parents, brothers, sisters, and children may also carry it and may want to discuss family testing. Some people with an RPL37 change are the first in their family to have it, so it does not always come from a parent.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for RPL37 variants usually uses a blood sample, saliva, or a cheek swab to read the RPL37 gene and look for DNA changes. Results can show whether a variant is present and how it is classified, though some findings remain uncertain and do not always predict symptoms.
When should I consider getting a genetic test?
There isn't yet a broadly established, RPL37-specific reason for genetic testing in routine care. Testing decisions are best made with a doctor or genetic counselor, based on your symptoms, blood test results, and family history.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, factors like lifestyle, environment, age, and medical history also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, seem less effective for another, or cause more side effects in someone else. Part of the difference comes from how the body breaks down, moves, and responds to a medicine, and inherited DNA changes are one common reason for that variation.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect the way a person responds to medications. It focuses on links between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the RPL37 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how they work, so any concerns about side effects, new symptoms, or changes in your treatment are best discussed with your doctor.
History
RPL37 entered the scientific literature as researchers worked to catalog the many genes that make up the human ribosome, the cell’s protein-making machinery. Early work focused on identifying its RNA and protein product, followed by mapping the RPL37 gene to its place in the human genome. From these first observations, research expanded steadily. As large genome projects advanced in the 1990s and 2000s, RPL37 was more clearly defined as part of a broader family of ribosomal protein genes. Its history is mainly tied to this wider effort to understand how basic cell machinery is built and regulated, rather than to a single public event or widely known medical milestone.